MeSH Browser

MeSH Supplementary: catumaxomab
Unique ID: C522419
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C522419
Entry Term(s): removab
Pharm Action: Gastrointestinal Agents
Registry Number: M2HPV837HO
Heading Mapped to: *Antibodies, Bispecific
Frequency: 76
Note: Used in the treatment of malignant ascites in patients with metastatic cancers; binds EpCAM and CD3 antigens. Extracorporeal PBMNC coating with catumaxomab may be an option to control intravascular cytokine release induced by therapeutic antibodies
Source: Cancer Immunol Immunother 2007 Sep;56(9):1397-406
Date of Entry: 2007/08/31
Revision Date: 2019/10/31

catumaxomab MeSH Supplementary Concept Data 2024